Male Infertility

Scientific Director

Sandro C. Esteves

Sandro C. Esteves

Androfert – Andrology and Human Reproduction Clinic
Campinas, Brazil

Scientific Committee

Gürkan Bozdağ

Gürkan Bozdağ

Society for Reproductive Endocrinology and Infertility
REI Clinic
Koc University
Peter Humaidan

Peter Humaidan

Fertility Clinic, Skive Regional Hospital
Faculty of Health, Aarhus University
Aarhus, Denmark
Jean-Noël Hugues

Jean-Noël Hugues

University Paris XIII
Paris, France
Matheus Roque

Matheus Roque

MATER PRIME – Reproductive Medicine
São Paulo, Brazil
Sesh K. Sunkara

Sesh K. Sunkara

King’s College London
London, UK
Alberto Vaiarelli

Alberto Vaiarelli

Genera Roma
Centre for Reproductive Medicine
Rome, Italy

· Sandro C. Esteves ·

Sandro C. Esteves, MD., PhD. is a reproductive urologist who specializes in treating male infertility, particularly its connection with assisted reproductive technology (ART). He is the founder and medical director of ANDROFERT, a Fertility Center based in Campinas, Brazil, dedicated to male reproductive health. He is also a Collaborating Professor of Urology at the State University of Campinas (UNICAMP), Brazil, and an Honorary Professor of Reproductive Medicine at Aarhus University, Denmark.

He obtained his MD. degree in 1990 from the Faculty of Medical Sciences of UNICAMP, Brazil. Subsequently, he completed his Urology residency at the same institution and a postdoctoral fellowship program at the Glickman’s Urological Institute at the Cleveland Clinic Foundation in the United States. He earned a master’s in Surgery from UNICAMP and a Ph.D. in Urology from the Federal University of S o Paulo (EPM-UNIFESP). Dr. Esteves has contributed to our understanding of male infertility with over 25 years of experience in clinical and academic settings. He has emphasized the limitations of basic semen analysis, the importance of assessing sperm DNA fragmentation in male infertility evaluations, and highlighted the relevance of varicocele and its treatment in enhancing male fertility prospects. He has also published extensively on his clinical experience with microsurgical treatment of infertile men, as well as on hormonal therapy for improving sperm retrieval success of men with non-obstructive azoospermia. Dr. Esteves has helped design novel stratification systems for infertile men with testicular dysfunction, for whom fertility prospects may improve after hormonal therapy, and for low prognosis infertile women undergoing ART. Dr. Esteves is a prolific author, and his research comprises over 350 published papers, numerous book chapters, and textbooks. With a Hirsch index of 71 and a citation count of around 17K, he is ranked among the top 1% of global researchers by the Science-Wide Author Databases of Standard Citation Indicators (Elsevier). Prof. Esteves plays an active role in the scientific community as a member of the Faculty Opinions in reproductive endocrinology and infertility and as a founding member of the POSEIDON group for reproductive medicine. Additionally, he holds positions as Associate Editor/Section Editor in several journals, including Human Reproduction, Andrology, Reproductive Biomedicine Online, Frontiers in Endocrinology, and the International Brazilian Journal of Urology. He also serves on the editorial boards of many scientific journals, including Nature Reviews Urology. Dr. Esteves’ clinic has been at the forefront of implementing cleanroom technology in the ART laboratory and adhering to ISO 9001 quality standards in Brazil. The ANDROFERT team is renowned for its strict quality standards and remarkable success rates in treating couples with male factor infertility. As a seasoned speaker, Dr. Esteves delivers over 50 lectures annually in Brazil and internationally. He has received multiple research grants and awards from national and international societies and currently holds the position of head of the Department of Andrology at the Brazilian Society of Human Reproduction.

· Gürkan Bozdağ ·

Gurkan Bozdag completed his Reproductive Medicine and Infertility Certification training at Hacettepe University. He gave postgraduate and doctorate courses in Reproductive Medicine and Infertility. He has more than 110 publications in international peer-reviewed journals, and some of his studies were awarded in the best poster category by The American Society of Reproductive Medicine. He took part in the editorial boards of various international and national scientific journals, including Human Reproduction, Clinical and Experimental Obstetrics & Gynecology, Frontiers in Endocrinology.

He took part in the regulatory boards of national and international symposiums and congresses in the field of reproductive medicine and in vitro fertilization. He also acted as the National Representative of Turkey in ESHRE (2020 – 2022) and as a co-author in the Guideline Development Group of Add-ons

He is currently the 2nd President of the Society for Reproductive Endocrinology and Infertility (TSRM) and is a member of the board of directors of national professional associations. From Jan-2022, he has been the Director of REI clinic in Koc University. He was also assigned as one of the executive member of ESHRE in June 2023.

· Peter Humaidan ·

Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. He is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient, and a past board member of the ESHRE SIG Endocrinology Group. Finally, he is also co-founder of the APHRODITE group which suggested a new classification of the infertile male into five sub-groups who might benefit from medical treatment in terms of spermatogenesis. He is in the Elsevier, Stanford global list of 2% top scientists, and he authored and co-authored 270 + articles (H-index 70, Google Scholar) in international peer reviewed journals as well as chapters in textbooks and the Danish guidelines for OHSS prevention. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.

· Jean-Noël Hugues ·

Professor Hugues was the head of Reproductive Medicine Unit at University Paris XIII.
He trained in Endocrinology and Gynaecology before being appointed as Professor of Reproductive Medicine and Development.
He succeeded in PhD in Biology of Reproduction at the University Paris XI
He was a member of many international scientific societies (ESHRE – ASRM – SGI)

His interest for the control of ovarian function and ovulation induction led him to conduct several clinical trials and to publish more than hundred articles in peer reviews.

· Matheus Roque ·

Matheus Roque is the Scientific Director at Origen – Center for Reproductive Medicine, Brazil. Dr. Roque obtained his degree in Medicine in 2003 at the Marilia Medical School, Mar lia, Brazil and he is currently working towards his PhD in Women’s Health at the Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. He obtained his Masters in Reproductive Medicine in 2012 at the Universitat Aut noma de Barcelona, Barcelona, Spain, and completed a Fellowship in Human Reproduction during 2009 –2010 at the Universidade Federal de S o Paulo, S o Paulo, Brazil. Dr. Roque has authored many scientific articles and book chapters, and has served as a reviewer for several indexed medical journals. He has been an active participant in many international and national congresses in reproductive medicine and urology, presenting abstracts and lectures. Dr. Roque has participated in the 2015 European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting as an Invited Speaker delivering the lecture Towards a “freeze-all” policy. Fertility and Sterility has recently acknowledged Dr. Roque in recognition of his contribution to the quality of the journal. Moreover, one of his papers featured in the top 5 most highly cited papers published in Fertility and Sterility during 2014 and 2015. He has been recently awarded with the GFI – Grant for Fertility Innovation, with the project entitled “Pharmacogenetic algorithm for individualized Controlled Ovarian Stimulation (iCOS)”. He is currently a member of ESHRE, the American Society for Reproductive Medicine, the Brazilian Society for Assisted Reproduction, and the Brazilian Society of Urology.

· Filippo Maria Ubaldi ·

Filippo Maria Ubaldi is Medical Doctor, Clinical Director at the GENERA Centres for Reproductive Medicine in Rome, Marostica, Umbertide and Naples, Italy. With academic degrees in Obstetrics and Gynaecology, Masters in Andrology and Reproductive Medicine, PhD at the Vrije Universiteit Brussel in Andrology and Reproductive Medicine, he is also intensely dedicated to educational, editorial and practitioner activities.
Co-author of 10 books on the topic of Reproductive Medicine, author and co-author of 146 scientific papers of which 131 are peer reviewed journals (PubMed 01/12/2018); author H-index is 43. Editor of the treaty on Reproductive Medicine ‘Medicina della Riproduzione Umana’ published in Italy in 2010. Invited as speaker at 422 National and International congresses on the topic of Reproductive Medicine and has been Scientific Coordinator of 74 congresses and courses. Member of the ESHRE Executive Committee during 2005-2009, he has been Chairman of the 26th ESHRE Annual Meeting held in Rome in June 2010. In 2014 he received the Italian National Scientific License as full Professor in Obstetrics and Gynaecology and between 2014-2015 has been member of the technical advisory board established by the Ministry of Health on heterologous fertilization.

· Alberto Vaiarelli ·

Alberto Vaiarelli is a Surgeon, specialist in Obstetrics and Gynaecology, PhD in Experimental Endocrinological and Metabolic Sciences with a Master’s Degree in Andrology and Reproductive Medicine and National Scientific Qualification for First Level University Professor. For more than 15 years he has been dealing with couple sterility and PMA techniques.

Medical and Scientific Coordinator of the Genera Roma center.

National Secretary of the Italian Society of Fertility-Sterility and Reproductive Medicine

Teacher in the disciplinary field of Gynecology and Reproductive Medicine in various Level I-II University Masters and Specialty courses in the Medical area.

Member of the teaching staff for second level Master’s degrees at the University of Pavia.

· Martin O. Savage ·

Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996.  His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 61 countries and has published 472 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.